CRISPR/Cas9在人病毒感染相关疾病治疗研究中的应用*

病毒感染相关疾病严重威胁人类的健康,目前的抗病毒疗法难以治愈慢性病毒性感染引起的一些疾病,如获得性免疫缺陷综合征和乙型肝炎等,因此迫切需要新的治疗方法。可直接靶向遗传物质的基因编辑技术或将成为对抗病毒的有力工具。作为一种可编程的核酸酶介导的新型基因编辑技术,CRISPR/Cas9系统因其具有编辑效率高、操作简单、成本低、适用范围广等优点,而成功应用于多种人类相关疾病的研究中,也为病毒感染相关疾病的研究以及开发新的治疗方法提供了新的技术手段。主要对CRISPR/Cas9系统的作用机制以及在人类常见的病毒感染相关疾病治疗研究中的最新进展进行综述。

The Application of CRISPR/Cas9 in the Treatment of Human Virus Infection-Related Diseases

Viral infection-related diseases pose a serious threat to human health. Current antiviral therapies cannot cure some diseases caused by chronic viral infections, such as AIDS and hepatitis B. Therefore, new treatment methods are urgently needed. Gene-editing technology that can directly target genetic material may become a powerful tool against viruses. As a new programmable nuclease-mediated gene-editing technology, the CRISPR/Cas9 system has been successfully applied to the research of a variety of human-related diseases due to its high editing efficiency, simple operation, low cost, and wide application range. It also provides new technical means for the research of viral infection-related diseases and the development of new treatment methods. The mechanism of the CRISPR/Cas9 system and the latest advances in the treatment of common human viral infection-related diseases were reviewed in the article.